Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel to Distribute SoftGenetics Software with Trisomal Dx Kits

NEW YORK (GenomeWeb News) – British medical diagnostics company Tepnel Life Sciences will market and distribute SoftGenetics’ genotyping software for use with its prenatal screening test, Tepnel said today.
 
Under the agreement, Tepnel will market the GeneMarker software with its Elucigene QST*R kits, which are rapid DNA diagnostic tests that use STR markers to detect three common trisomal disorders, including Down syndrome, Edwards syndrome, and Patau syndrome.
 
Using the GeneMarker software with the kits “will considerably streamline the data analysis process and results reporting time for users,” Tepnel said.
 
Tepnel is based in Manchester, UK, and it has laboratories in the US and in France. It provides tests and reagents for molecular diagnostics and biomedical research.
 
SoftGenetics has facilities in Stamford, Conn., and in State College, Pa., and it focuses on developing software for research and diagnostic applications.
 
Financial terms of the agreement were not released.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.